april
sever
acut
respiratori
syndrom
sar
like
diseas
emerg
saudi
arabia
august
world
health
organ
receiv
report
case
infect
caus
novel
human
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
previou
name
hcovemc
includ
death
sever
countri
includ
saudi
arabia
qatar
jordan
unit
arab
emir
unit
kingdom
franc
germani
itali
tunisia
http
eight
merscov
cluster
report
suggest
persontoperson
transmiss
diseas
howev
transmiss
merscov
appear
less
effici
sarscoronaviru
sarscov
first
new
infecti
diseas
identifi
centuri
approxim
mortal
rate
genet
merscov
close
relat
sarscov
clinic
sever
respiratori
ill
renal
failur
caus
merscov
infect
similar
symptomolog
relat
sar
therefor
outbreak
merscov
infect
rais
seriou
concern
potenti
global
pandem
order
sar
accordingli
pursuant
develop
effect
vaccin
antivir
agent
first
step
requir
identif
neutral
inhibitori
activ
antimerscov
vaccin
therapeut
well
known
sarscov
gain
cellular
entri
receptor
angiotensin
convert
enzym
wherea
merscov
util
dipeptidyl
also
known
entri
receptor
similar
sarscov
spike
protein
merscov
also
play
import
role
receptor
bind
viral
entri
major
protein
caus
viru
infect
protein
ideal
target
vaccin
merscov
entri
inhibitor
studi
produc
pseudoviru
bear
fulllength
protein
merscov
envdefect
luciferaseexpress
backbon
establish
pseudovirusbas
inhibit
assay
detect
neutral
antibodi
antimerscov
entri
inhibitor
method
proven
safe
conveni
reliabl
effect
rapid
detect
neutral
antibodi
viral
entri
inhibitor
merscov
first
detect
abil
gener
merscov
pseudoviru
infect
cell
variou
tissu
differ
host
includ
human
cell
line
hela
well
mink
pig
canin
mdck
monkey
vero
vero
tabl
pseudoviru
express
vsvg
includ
posit
control
target
cell
respect
infect
merscov
pseudoviru
normal
equal
content
luciferas
activ
measur
h
infect
shown
figur
almost
test
human
cell
varieti
anim
cell
could
infect
produc
pseudoviru
particularli
merscov
pseudoviru
infect
sar
receptorexpress
cell
maintain
high
infect
abil
identifi
merscov
receptor
cell
addit
human
cell
type
anim
cell
type
includ
mdck
vero
vero
infect
merscov
pseudoviru
significantli
higher
degre
cell
type
hela
howev
high
infect
observ
result
also
demonstr
vsvg
posit
control
could
highli
infect
almost
test
cell
type
possibl
due
broad
host
rang
vsvg
capabl
infect
multipl
tissu
variou
host
env
pseudoviru
neg
control
unabl
infect
test
cell
line
figur
next
perform
western
blot
identifi
incorpor
merscov
packag
merscov
pseudoviru
shown
figur
clear
band
correspond
merscov
protein
identifi
gener
pseudoviru
merscov
use
antibodi
merscov
protein
respect
merscov
antigen
detect
vsvg
pseudoviru
contain
data
suggest
specif
protein
merscov
effect
incorpor
packag
particl
gener
merscov
pseudoviru
western
blot
also
carri
detect
express
cell
suscept
pseudotyp
merscov
among
test
cell
exhibit
highest
express
follow
express
vero
vero
mdck
cell
rel
low
level
protein
detect
cell
cell
nevertheless
express
shown
hela
figur
use
merscov
pseudoviru
establish
pseudoviru
inhibit
assay
evalu
neutral
activ
sera
mice
vaccin
recombin
protein
srbdfc
contain
receptorbind
domain
rbd
residu
merscov
spike
fuse
fc
human
igg
shown
figur
three
test
repres
mous
sera
demonstr
neutral
activ
merscov
pseudoviru
infect
cell
titer
control
sera
mice
immun
pb
show
neutral
activ
test
pseudoviru
sera
evalu
neutral
activ
merscov
infect
use
live
merscovbas
inhibit
assay
result
indic
neutral
antibodi
sera
test
sera
control
sera
correspond
test
pseudoviru
inhibit
assay
figur
suggest
establish
pseudovirusbas
inhibit
assay
suffici
reliabl
evalu
neutral
antibodi
induc
candid
vaccin
merscov
use
establish
method
next
detect
inhibit
activ
sever
hiv
entri
inhibitor
inhibitori
activ
merscov
entri
cell
shown
figur
small
molecul
hiv
entri
inhibitor
target
anhydridemodifi
human
serum
albumin
hphsa
target
receptor
could
inhibit
merscov
pseudoviru
infect
concentr
respect
test
cell
howev
highli
potent
peptid
hiv
entri
inhibitor
show
moder
inhibitori
activ
merscov
pseudoviru
infect
confirm
result
detect
inhibitori
abil
hphsa
compound
well
peptid
cell
line
interestingli
result
similar
compound
test
cell
around
merscov
pseudoviru
entri
inhibit
concentr
figur
two
compound
carri
net
neg
charg
may
interact
posit
charg
residu
spike
protein
pseudotyp
merscov
similar
way
inhibit
infect
hiv
envelop
virus
inhibit
sarscov
infect
inhibit
human
papilloma
viru
hpv
infect
hphsa
howev
peptid
show
inhibitori
activ
figur
suggest
peptid
unabl
inhibit
merscov
pseudoviru
entri
cell
expect
none
compound
inhibit
pseudotyp
contain
vsvg
test
cell
line
figur
detect
potenti
cytotox
identifi
compound
cell
use
test
inhibitori
activ
merscov
pseudoviru
shown
figur
hphsa
signific
cytotox
concentr
high
exhibit
cytotox
cell
concentr
caus
cytotox
howev
concentr
caus
inhibit
merscov
pseudoviru
infect
select
index
data
indic
decreas
infect
peudotyp
merscov
presenc
compound
due
cytotox
associ
inhibit
merscov
entri
result
confirm
establish
pseudoviru
inhibit
assay
could
use
effect
way
rapidli
screen
merscov
entri
inhibitor
angiotensinconvert
enzym
confirm
receptor
sarscov
merscov
shown
bind
target
cell
use
receptor
studi
gener
pseudotyp
merscov
base
viral
surfac
protein
detect
infect
differ
cell
type
inde
gener
pseudoviru
abl
infect
varieti
cell
line
includ
human
nonhuman
cell
type
gener
cell
suscept
consist
wildtyp
merscov
report
previous
abl
maintain
high
infect
cell
mdck
vero
vero
incap
infect
hela
cell
express
infect
cell
rel
lower
wildtyp
viru
possibl
pseudotyp
merscov
contain
viral
protein
abil
singlecycl
infect
lack
capabl
multipl
round
replic
might
lower
infect
wildtyp
merscov
contain
viral
protein
necessari
viru
replic
note
merscov
pseudoviru
rel
higher
infect
cell
undetect
express
suggest
infect
merscov
pseudoviru
might
complet
associ
express
level
similar
phenomena
observ
pohlmann
colleagu
show
lentivir
pseudotyp
lower
infect
cell
differ
batch
maintain
variant
infect
report
shown
hek
cell
undetect
rel
higher
infect
wildtyp
merscov
may
possibl
like
sarscov
altern
receptor
dcsign
andor
lsign
addit
merscov
might
also
altern
receptor
identifi
far
notabl
peptid
deriv
region
moder
inhibitori
activ
merscov
entri
cell
exhibit
inhibit
merscov
entri
cell
result
suggest
peptid
may
interact
conform
merscov
protein
subunit
induc
bind
subunit
notyetidentifi
altern
receptor
cell
howev
peptid
may
abl
interact
conform
merscov
protein
subunit
induc
bind
subunit
welldefin
receptor
cell
live
virusbas
inhibit
assay
gener
use
detect
neutral
antibodi
infect
sarscov
coronavirus
howev
carri
type
inhibit
assay
necessari
util
biosafeti
level
facil
unfortun
strict
condit
often
inconveni
access
mani
research
contrast
pseudovirusbas
inhibit
assay
perform
without
requir
laboratori
consider
simplifi
detect
neutral
antibodi
method
involv
live
virus
therefor
safe
carri
moreov
demonstr
consist
neutral
result
live
virusbas
inhibit
assay
establish
pseudovirusbas
inhibit
assay
neutral
result
also
consist
obtain
experi
antisera
mice
immun
anoth
rbd
fragment
contain
residu
merscov
protein
report
recent
result
suggest
viabl
altern
rapid
detect
neutral
antibodi
merscov
natur
infect
preclin
evalu
candid
vaccin
facil
avail
furthermor
absenc
facil
pseudovirusbas
inhibit
assay
provid
conveni
reliabl
way
rapidli
screen
compound
peptidebas
merscov
entri
inhibitor
test
neutral
antibodi
easi
product
pseudoviru
rapid
readout
detect
inhibit
method
particularli
suitabl
handl
larg
varieti
sampl
short
period
time
studi
show
establish
merscov
inhibit
assay
safe
conveni
pseudovirusbas
altern
liveviru
restrict
use
rapidli
screen
merscov
entri
inhibitor
well
evalu
vaccineinduc
neutral
antibodi
highli
pathogen
merscov
studi
anim
approv
institut
anim
care
use
committe
new
york
blood
center
approv
anim
studi
carri
strict
accord
recommend
american
veterinari
medic
associ
avma
guidelin
approv
protocol
hela
mdck
vero
vero
cell
use
detect
pseudoviru
infect
identif
express
merscov
receptor
inform
cell
line
well
origin
provid
specif
describ
tabl
codonoptim
gene
express
fulllength
protein
merscov
humanbetacoronaviru
hcovemc
genbank
access
synthes
genscript
nanj
china
replac
ntermin
signal
peptid
residu
signal
sequenc
insert
vector
invitrogen
carlsbad
ca
construct
recombin
merscov
plasmid
rmerscov
contain
gene
confirm
correct
insert
sequenc
analysi
gener
merscov
pseudoviru
done
previous
describ
modif
briefli
cell
atcc
manassa
va
cotransfect
plasmid
encod
envdefect
luciferaseexpress
rmerscov
plasmid
respect
tissu
cultur
flask
use
calcium
phosphat
method
cell
chang
fresh
dmem
h
later
supernat
harvest
h
posttransfect
use
singlecycl
infect
plasmid
encod
vesicular
stomat
viru
g
protein
vector
cotransfect
plasmid
gener
vsvg
pseudoviru
pseudoviru
without
env
env
control
content
produc
merscov
pseudoviru
quantifi
elisa
previous
describ
modif
briefli
elisa
plate
precoat
hivig
overnight
block
h
lyse
pseudoviru
ad
plate
incub
h
wash
plate
respect
incub
mab
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
h
substrat
tmb
zyme
carlsbad
ca
ad
reaction
stop
n
absorb
nm
measur
elisa
plate
reader
tecan
san
jose
ca
detect
infect
differ
target
cell
plate
variou
sourc
tabl
respect
infect
merscov
pseudoviru
fresh
dmem
ad
h
postinfect
rlu
measur
h
later
ultra
luminomet
tecan
western
blot
perform
detect
merscov
protein
gener
pseudoviru
identifi
express
cell
suscept
merscov
pseudoviru
previous
describ
modif
briefli
lyse
pseudoviru
ngml
cell
lysat
total
protein
respect
separ
trisglycin
gel
transfer
nitrocellulos
membran
block
nonfat
milk
pbst
overnight
blot
respect
incub
anti
merscov
prepar
laboratori
goat
r
system
minneapoli
mn
h
room
temperatur
three
wash
blot
incub
hrpconjug
antimous
igg
merscov
invitrogen
antigoat
igg
r
system
h
room
temperatur
signal
visual
ecl
western
blot
substrat
reagent
amersham
hyperfilm
ge
healthcar
construct
express
purif
recombin
protein
fuse
fc
srbdfc
done
previous
describ
briefli
gene
encod
rbd
residu
merscov
protein
amplifi
pcr
use
synthes
codonoptim
fulllength
sequenc
merscov
templat
digest
ecor
bgl
ii
restrict
enzym
insert
express
vector
hereinaft
name
fc
invivogen
san
diego
ca
sequenceconfirm
recombin
plasmid
transfect
cell
atcc
manassa
va
seed
h
transfect
follow
replac
cultur
medium
serumfre
dmem
invitrogen
carlsbad
ca
h
later
collect
supernat
contain
express
protein
h
posttransfect
recombin
protein
purifi
protein
affin
chromatographi
ge
healthcar
piscataway
nj
accord
manufactur
instruct
mice
subcutan
immun
recombin
merscov
srbdfc
protein
formul
freund
complet
adjuv
sigma
st
loui
mo
boost
immunogen
freund
incomplet
adjuv
interv
sera
collect
day
vaccin
use
detect
neutral
activ
pseudoviru
inhibit
assay
establish
detect
neutral
activ
vaccin
mous
sera
inhibitori
abil
antivir
agent
infect
merscov
pseudoviru
target
cell
briefli
pseudoviruscontain
supernat
respect
incub
serial
dilut
mous
sera
synthet
compound
h
ad
target
cell
preplat
cultur
plate
cellswel
twentyfour
hour
later
cell
refe
fresh
medium
follow
lyse
cell
h
later
use
cell
lysi
buffer
promega
transfer
lysat
luminomet
plate
luciferas
substrat
promega
ad
plate
rel
luciferas
activ
determin
inhibit
merscov
pseudoviru
present
inhibit
neutral
antibodi
titer
mous
sera
infect
merscov
live
viru
detect
previous
describ
sarscov
modif
briefli
serial
dilut
mous
sera
incub
tissu
cultur
infect
dose
viru
h
prior
addit
monolay
vero
cell
triplic
viru
supernat
remov
replac
fresh
medium
h
cultur
cytopath
effect
cpe
well
observ
daili
record
day
postinfect
neutral
titer
mous
antisera
complet
prevent
cpe
well
calcul
vitro
cytotox
synthet
compound
target
cell
measur
xtt
assay
previous
describ
modif
briefli
serial
dilut
compound
noncolor
medium
ad
equal
volum
cell
tissu
cultur
plate
incub
day
xtt
solut
mgml
contain
phenazinemethosulph
pm
ad
four
hour
later
absorb
nm
measur
elisa
plate
reader
author
declar
compet
interest
ld
yz
sj
design
research
gz
ld
cm
yl
vkp
lw
fy
bjz
perform
research
gz
ld
yz
analyz
data
ld
yz
sj
wrote
modifi
paper
author
read
approv
final
manuscript
